← Leaderboards
Richard S Hayes
Cancer Epidemiology And Genetics
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Cancer Epidemiology And Genetics
Same institution · by research overlap
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskEarly DiagnosisQuestionnairesPredispositionMass ScreeningNeoplasm /Cancer DiagnosisReportingLifestyleBiochemicalInvestigationMalignant Neoplasm Of BreastMalignant NeoplasmsMedicalMortality Vital StatisticsClinical ResearchAdenomatous PolypsDisease /Disorder EtiologyCancer EtiologyCohortBiomarkerGene Environment InteractionHuman SubjectGenetic SusceptibilityColorectal Neoplasms
Grant awards (11)
Studies of Occupational Cancer$4,308,955
Z01 · FY2008 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,342,091
Z01 · FY2008 · CA · contact PI
Studies of Occupational Cancer$4,687,795
Z01 · FY2007 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$912,943
Z01 · FY2007 · CA · contact PI
Etiologic Studies in the PLCO Trial$0
Z01 · FY2006 · CP · contact PI
Etiologic Studies in the PLCO Trial$0
Z01 · FY2005 · CP
Etiologic Studies in PLCO Trial$0
Z01 · FY2004 · CP
Etiologic Studies in PLCO Trial$0
Z01 · FY2003 · CP
Etiology of Colorectal Tumors in the PLCO Trial$0
Z01 · FY2002 · CP
Etiology of Colorectal Tumors in the PLCO Trial$0
Z01 · FY2001 · CP
ETIOLOGY OF COLORECTAL TUMORS IN THE PLCO TRIAL$0
Z01 · FY2000 · CP